Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts

Tina M. Crone, Shani L. Schalles, Catharine M. Benedict, Weihua Pan, Ling Ren, Sarah E. Loy, Harriet Isom, Gary Clawson

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The B2 family represents a group of short repetitive sequences that are found throughout the rodent genome and are analogous to the human Alu sequences. Certain B2 subfamilies are transcribed by RNA polymerase III (pol III), and this transcription is in part controlled by the retinoblastoma protein. In addition to their putative role in retrotranspositional events, these actively transcribed B2 RNAs show a predicted highly stable secondary structure. Although B2 transcripts are normally confined to the nucleus, they demonstrate altered compartmentation after carcinogen treatment, in cancers, and in immortalized and/or transformed cell lines, the significance of which is unclear. Because modulation of B2 transcripts did not seem feasible with an antisense approach, we designed a triple ribozyme (TRz) construct to down- regulate B2 transcripts. The B2-targeted TRz undergoes efficient self- cleavage, resulting in liberation of the internal hammerhead Rz, which we targeted to a single-stranded region of the consensus B2 sequence. The liberated internal targeted Rz was 20 times more active than the corresponding double-G mutant construct that could not undergo self-cleavage, and 5 times more active than the same Rz flanked by nonspecific vector sequences. The B2-targeted TRz was used to develop stable transfectant clones from an SV40-immortalized hepatocyte cell line. These transfectant clones all showed variably reduced growth rates, accompanied by significant reductions in both cytoplasmic and nuclear B2 RNA levels: linear regression analyses showed that their growth rates were directly related to residual cytoplasmic B2 levels. Reverse-transcription polymerase chain reaction (RT-PCR) analyses documented efficient self-liberation of the internal targeted Rz in vivo, and showed that the relative cytoplasmic expression levels generally paralleled the magnitude of the decrease in B2 transcripts. The RT-PCR analyses further demonstrated that up to 20% of the Rz was located in the nucleus, which presumably reflects competition between autocatalytic processing and nucleocytoplasmic transport of the initial TRz transcript.

Original languageEnglish (US)
Pages (from-to)1114-1123
Number of pages10
JournalHepatology
Volume29
Issue number4
DOIs
StatePublished - Jan 1 1999

Fingerprint

Catalytic RNA
Growth
Reverse Transcription
Clone Cells
RNA Polymerase III
Nuclear RNA
Polymerase Chain Reaction
Retinoblastoma Protein
Transformed Cell Line
Cell Nucleus Active Transport
Nucleic Acid Repetitive Sequences
Consensus Sequence
Carcinogens
Hepatocytes
Rodentia
Linear Models
Down-Regulation
Regression Analysis
Genome
RNA

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Crone, T. M., Schalles, S. L., Benedict, C. M., Pan, W., Ren, L., Loy, S. E., ... Clawson, G. (1999). Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts. Hepatology, 29(4), 1114-1123. https://doi.org/10.1002/hep.510290449
Crone, Tina M. ; Schalles, Shani L. ; Benedict, Catharine M. ; Pan, Weihua ; Ren, Ling ; Loy, Sarah E. ; Isom, Harriet ; Clawson, Gary. / Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts. In: Hepatology. 1999 ; Vol. 29, No. 4. pp. 1114-1123.
@article{83087afc957749e9a3fc964c45d9b7f4,
title = "Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts",
abstract = "The B2 family represents a group of short repetitive sequences that are found throughout the rodent genome and are analogous to the human Alu sequences. Certain B2 subfamilies are transcribed by RNA polymerase III (pol III), and this transcription is in part controlled by the retinoblastoma protein. In addition to their putative role in retrotranspositional events, these actively transcribed B2 RNAs show a predicted highly stable secondary structure. Although B2 transcripts are normally confined to the nucleus, they demonstrate altered compartmentation after carcinogen treatment, in cancers, and in immortalized and/or transformed cell lines, the significance of which is unclear. Because modulation of B2 transcripts did not seem feasible with an antisense approach, we designed a triple ribozyme (TRz) construct to down- regulate B2 transcripts. The B2-targeted TRz undergoes efficient self- cleavage, resulting in liberation of the internal hammerhead Rz, which we targeted to a single-stranded region of the consensus B2 sequence. The liberated internal targeted Rz was 20 times more active than the corresponding double-G mutant construct that could not undergo self-cleavage, and 5 times more active than the same Rz flanked by nonspecific vector sequences. The B2-targeted TRz was used to develop stable transfectant clones from an SV40-immortalized hepatocyte cell line. These transfectant clones all showed variably reduced growth rates, accompanied by significant reductions in both cytoplasmic and nuclear B2 RNA levels: linear regression analyses showed that their growth rates were directly related to residual cytoplasmic B2 levels. Reverse-transcription polymerase chain reaction (RT-PCR) analyses documented efficient self-liberation of the internal targeted Rz in vivo, and showed that the relative cytoplasmic expression levels generally paralleled the magnitude of the decrease in B2 transcripts. The RT-PCR analyses further demonstrated that up to 20{\%} of the Rz was located in the nucleus, which presumably reflects competition between autocatalytic processing and nucleocytoplasmic transport of the initial TRz transcript.",
author = "Crone, {Tina M.} and Schalles, {Shani L.} and Benedict, {Catharine M.} and Weihua Pan and Ling Ren and Loy, {Sarah E.} and Harriet Isom and Gary Clawson",
year = "1999",
month = "1",
day = "1",
doi = "10.1002/hep.510290449",
language = "English (US)",
volume = "29",
pages = "1114--1123",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

Crone, TM, Schalles, SL, Benedict, CM, Pan, W, Ren, L, Loy, SE, Isom, H & Clawson, G 1999, 'Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts', Hepatology, vol. 29, no. 4, pp. 1114-1123. https://doi.org/10.1002/hep.510290449

Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts. / Crone, Tina M.; Schalles, Shani L.; Benedict, Catharine M.; Pan, Weihua; Ren, Ling; Loy, Sarah E.; Isom, Harriet; Clawson, Gary.

In: Hepatology, Vol. 29, No. 4, 01.01.1999, p. 1114-1123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts

AU - Crone, Tina M.

AU - Schalles, Shani L.

AU - Benedict, Catharine M.

AU - Pan, Weihua

AU - Ren, Ling

AU - Loy, Sarah E.

AU - Isom, Harriet

AU - Clawson, Gary

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The B2 family represents a group of short repetitive sequences that are found throughout the rodent genome and are analogous to the human Alu sequences. Certain B2 subfamilies are transcribed by RNA polymerase III (pol III), and this transcription is in part controlled by the retinoblastoma protein. In addition to their putative role in retrotranspositional events, these actively transcribed B2 RNAs show a predicted highly stable secondary structure. Although B2 transcripts are normally confined to the nucleus, they demonstrate altered compartmentation after carcinogen treatment, in cancers, and in immortalized and/or transformed cell lines, the significance of which is unclear. Because modulation of B2 transcripts did not seem feasible with an antisense approach, we designed a triple ribozyme (TRz) construct to down- regulate B2 transcripts. The B2-targeted TRz undergoes efficient self- cleavage, resulting in liberation of the internal hammerhead Rz, which we targeted to a single-stranded region of the consensus B2 sequence. The liberated internal targeted Rz was 20 times more active than the corresponding double-G mutant construct that could not undergo self-cleavage, and 5 times more active than the same Rz flanked by nonspecific vector sequences. The B2-targeted TRz was used to develop stable transfectant clones from an SV40-immortalized hepatocyte cell line. These transfectant clones all showed variably reduced growth rates, accompanied by significant reductions in both cytoplasmic and nuclear B2 RNA levels: linear regression analyses showed that their growth rates were directly related to residual cytoplasmic B2 levels. Reverse-transcription polymerase chain reaction (RT-PCR) analyses documented efficient self-liberation of the internal targeted Rz in vivo, and showed that the relative cytoplasmic expression levels generally paralleled the magnitude of the decrease in B2 transcripts. The RT-PCR analyses further demonstrated that up to 20% of the Rz was located in the nucleus, which presumably reflects competition between autocatalytic processing and nucleocytoplasmic transport of the initial TRz transcript.

AB - The B2 family represents a group of short repetitive sequences that are found throughout the rodent genome and are analogous to the human Alu sequences. Certain B2 subfamilies are transcribed by RNA polymerase III (pol III), and this transcription is in part controlled by the retinoblastoma protein. In addition to their putative role in retrotranspositional events, these actively transcribed B2 RNAs show a predicted highly stable secondary structure. Although B2 transcripts are normally confined to the nucleus, they demonstrate altered compartmentation after carcinogen treatment, in cancers, and in immortalized and/or transformed cell lines, the significance of which is unclear. Because modulation of B2 transcripts did not seem feasible with an antisense approach, we designed a triple ribozyme (TRz) construct to down- regulate B2 transcripts. The B2-targeted TRz undergoes efficient self- cleavage, resulting in liberation of the internal hammerhead Rz, which we targeted to a single-stranded region of the consensus B2 sequence. The liberated internal targeted Rz was 20 times more active than the corresponding double-G mutant construct that could not undergo self-cleavage, and 5 times more active than the same Rz flanked by nonspecific vector sequences. The B2-targeted TRz was used to develop stable transfectant clones from an SV40-immortalized hepatocyte cell line. These transfectant clones all showed variably reduced growth rates, accompanied by significant reductions in both cytoplasmic and nuclear B2 RNA levels: linear regression analyses showed that their growth rates were directly related to residual cytoplasmic B2 levels. Reverse-transcription polymerase chain reaction (RT-PCR) analyses documented efficient self-liberation of the internal targeted Rz in vivo, and showed that the relative cytoplasmic expression levels generally paralleled the magnitude of the decrease in B2 transcripts. The RT-PCR analyses further demonstrated that up to 20% of the Rz was located in the nucleus, which presumably reflects competition between autocatalytic processing and nucleocytoplasmic transport of the initial TRz transcript.

UR - http://www.scopus.com/inward/record.url?scp=0032898741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032898741&partnerID=8YFLogxK

U2 - 10.1002/hep.510290449

DO - 10.1002/hep.510290449

M3 - Article

C2 - 10094955

AN - SCOPUS:0032898741

VL - 29

SP - 1114

EP - 1123

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -

Crone TM, Schalles SL, Benedict CM, Pan W, Ren L, Loy SE et al. Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts. Hepatology. 1999 Jan 1;29(4):1114-1123. https://doi.org/10.1002/hep.510290449